TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 120 filers reported holding TURNING POINT THERAPEUTICS I in Q1 2020. The put-call ratio across all filers is 1.37 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $7,705,000 | -15.0% | 115,983 | -0.2% | 0.28% | -15.2% |
Q2 2021 | $9,070,000 | -46.9% | 116,251 | -35.6% | 0.33% | -46.4% |
Q1 2021 | $17,074,000 | -60.8% | 180,508 | -49.4% | 0.62% | -57.3% |
Q4 2020 | $43,505,000 | +66.6% | 357,038 | +19.4% | 1.44% | +34.3% |
Q3 2020 | $26,121,000 | +88.7% | 299,008 | +39.5% | 1.08% | +78.3% |
Q2 2020 | $13,842,000 | +291.5% | 214,309 | +170.7% | 0.60% | +194.1% |
Q1 2020 | $3,536,000 | – | 79,180 | – | 0.20% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 2,750,000 | $260,122,000 | 5.80% |
Burrage Capital Management LLC | 72,164 | $6,826,000 | 5.53% |
Consonance Capital Management LP | 450,396 | $42,603,000 | 4.54% |
MPM BioImpact LLC | 269,186 | $25,462,000 | 3.20% |
Orbimed Advisors | 2,361,327 | $223,358,000 | 2.09% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 81,541 | $7,711,000 | 2.04% |
SECTORAL ASSET MANAGEMENT INC | 257,879 | $24,393,000 | 1.85% |
Nicholas Investment Partners, LP | 218,847 | $20,701,000 | 1.44% |
Logos Global Management LP | 140,000 | $13,243,000 | 1.29% |
SILVERARC CAPITAL MANAGEMENT, LLC | 16,741 | $1,584,000 | 0.86% |